In-house Drone Battery Production Capacity to Double by Mid-2027 FREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) — Enovix Corporation (Nasdaq: ENVX) (“Enovix”), a developer and manufacturer of advanced lithium-ion batteries, including proprietary silicon-anode architectures, highlighted that its drone and defense battery portfolio manufactured in South Korea is compliant with the Trade Agreements Act (TAA), expanding the company’s ability to serve U.S. government defense programs. Enovix is doubling its in-house drone battery production capacity in South Korea by mid-2027 to support growing demand from the U.S. and allied government customers. “Secure access to high-performance batteries is increasingly critical to the national security of the United States and its allies,” said Ryan Benton, Interim Chief Executive Officer of Enovix....

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, announces that it has applied for a voluntary delisting of its Class B subordinate voting shares (“Class B Shares”) from the Canadian Securities Exchange (the “CSE”). The delisting from the CSE will not affect the Company’s listing on the...

MONTREAL, Sept. 01, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has received regulatory approval from INVIMA, the Colombian health regulatory agency, for TAVALISSE® (fostamatinib disodium hexahydrate) for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response, loss of response, or intolerance to prior treatment with corticosteroids and intravenous immunoglobulin.1 “We are pleased to receive regulatory approval of TAVALISSE in Colombia, providing an important new therapeutic option for adult patients living with chronic immune thrombocytopenia,” said Samira Sakhia, President and CEO of Knight Therapeutics. “This approval represents a meaningful step in addressing...

The Phase 3 BiPASS™ study of Illuccix® and Gozellix® for prostate cancer imaging in the pre-biopsy setting has completed enrollment of 350 patients. Telix has positively engaged with the FDA on a New Drug Application (NDA) pathway in the U.S. that would support new product reimbursement and broaden access to 68Ga-PSMA-PET imaging across a significantly larger patient population. BiPASS is designed to evaluate the diagnostic performance of 68Ga-PSMA-11 PET combined with MRI for the detection of prostate cancer prior to biopsy.MELBOURNE, Australia and INDIANAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announced completion of patient enrollment in the Phase 3 BiPASS™ study of its commercial PSMA-PET1 imaging agents, Illuccix® (kit for the preparation...

EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Jefferies Healthcare Services Conference on September 15, 2026. Brent Guerisoli, Chief Executive Officer and John Gochnour, President and Chief Operating Officer, will participate in a fireside chat on September 15, 2026 at 3:00 p.m. Central Time. A live webcast of the event will be accessible at the following address:https://event.summitcast.com/view/GhCtEPrzrHFSChRnGR9UnE/RvNHgc3873QZCoZJf4w5aA. About Pennant: The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living...

BETHESDA, MD, Sept. 01, 2026 (GLOBE NEWSWIRE) — HWH International Inc. (Nasdaq: HWH) (“HWH” or the “Company”) today announced a transition in its executive leadership. Chan Heng Fai (“Mr. Chan”), the Company’s Chairman of the Board and Chief Executive Officer, will step down from both positions, to be succeeded by Mr. Liu Ming Hui as Executive Chairman and Dr. Liu Ming Xing as Chief Executive Officer, effective September 1, 2026. Mr. Chan, 81, has served as HWH’s Chairman since 2021 and has led the Company since its formation, through its Nasdaq listing and its most recent strategic financing. Citing his age and other personal commitments, Mr. Chan will step down as Chairman and Chief Executive Officer, while continuing to serve as a director of the Company. Over a business career spanning more...

New Location Marks 6th Store in CaliforniaBlack Rock Coffee BarOpening September 2nd in Lake ElsinoreBlack Rock Coffee BarNew Lake Elsinore, CA Location Coming on September 2ndScottsdale, AZ, Sept. 01, 2026 (GLOBE NEWSWIRE) — Black Rock Coffee Bar, the Oregon-born boutique coffee chain celebrated for its specialty coffees, teas, smoothies, and signature Fuel® energy drinks, is growing its footprint in California with the opening of a new store in Lake Elsinore.  The store, located at 321 Summerhill Dr, will officially open its doors on Wednesday, September 2nd. This opening marks Black Rock’s sixth California location and reinforces the brand’s steady expansion across the state. Guests can enjoy the following specials during opening week: Wednesday, 9/2: Free 16oz Drinks Thursday, 9/3: Buy One, Get...

SYDNEY and AUCKLAND, New Zealand, Sept. 01, 2026 (GLOBE NEWSWIRE) — StoneX Financial Pty Ltd (SFA), a subsidiary of StoneX Group Inc. (NASDAQ: SNEX), today announced that it has received approval from the Financial Markets Authority (FMA) in New Zealand to offer milk price risk management solutions to retail industry participants in the country. This licence enables StoneX to provide dairy farmers with tools to help them manage their exposure to milk price volatility and improve income certainty. A key focus of the initiative is to expand access to risk management tools for sharemilkers, a segment that has historically faced limited access to hedging solutions despite often being among the most financially exposed participants in the dairy supply chain. Liam Fenton, Global Head of Dairy & Food Group, StoneX, commented: “New...